HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
New England Journal of Medicine2014Vol. 371(25), pp. 2383–2393
Citations Over TimeTop 1% of 2014 papers
Anand Rohatgi, Amit Khera, Jarett D. Berry, Edward G. Givens, Colby Ayers, Kyle E. Wedin, Ian J. Neeland, Ivan S. Yuhanna, Daniel Rader, James A. de Lemos, Philip W. Shaul
Abstract
Cholesterol efflux capacity, a new biomarker that characterizes a key step in reverse cholesterol transport, was inversely associated with the incidence of cardiovascular events in a population-based cohort. (Funded by the Donald W. Reynolds Foundation and others.).
Related Papers
- → Detergent-Mediated Phospholipidation of Plasma Lipoproteins Increases HDL Cholesterophilicity and Cholesterol Efflux via SR-BI(2006)29 cited
- → Rate‐limiting factors of cholesterol efflux in reverse cholesterol transport: Acceptors and donors(2010)15 cited
- → Apolipoprotein A-I-Containing Particles and Reverse Cholesterol Transport in IDDM(1992)20 cited
- → Delineation of the Role of Pre-β 1 -HDL in Cholesterol Efflux Using Isolated Pre-β 1 -HDL(2002)29 cited
- [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].(2016)